GL1X · GenesisL1 explorer

Research workbench

Structure-based design of a new series of N-piperidin-3-ylpyrimidine- 5-carboxamides as renin inhibitors

Analyse Structure-based design of a new series of N-piperidin-3-ylpyrimidine… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5SXN
Type
protein
Length
672 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Renin
EC
3.4.23.15
UniProt
P00797
Ligands
74U, NAG
Pockets
5 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARenin (EC 3.4.23.15)protein33616% helix, 44% strandP00797
BRenin (EC 3.4.23.15)protein33616% helix, 44% strandP00797

Ligands and binding sites

  • 74U · N-[(furan-2-yl)methyl]-2-phenylquinazolin-4-amine · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains A, B
  • PEG · Di(hydroxyethyl)ether · additive · 2 copies · chains A, B
  • PGE · Triethylene glycol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110440.840.8513274U, PEG
25580.710.7954empty
32780.610.8034empty
41950.500.7730PEG
5550.310.7617empty

Interfaces

1 interface between chains.

  • A–B · 917 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 5SXN · Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.